Chronic solvent-induced encephalopathy: European consensus of neuropsychological characteristics, assessment, and guidelines for diagnostics

NeuroToxicology

Volumn 33, Issue 4, 2012, Pages 710-726

  Van Valen, Evelien ^a   Van Thriel, Christoph ^b   Akila, Ritva ^c   Nilson, Linda Nordling ^d   Bast Pettersen, Rita ^e   Sainio, Markku ^c   Van Dijk, Frank ^a   Van der Laan, Gert ^a   Verberk, Maarten ^a   Wekking, Ellie ^a,f  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^c FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

^f Dijke en Duin   (Netherlands)

Author keywords

Chronic solvent induced encephalopathy; Consensus; Diagnostic criteria; Neuropsychological assessment; Occupational disease; Organic solvents

Indexed keywords

ARTICLE; ATTENTION; BRAIN DISEASE; CHRONIC SOLVENT INDUCED ENCEPHALOPATHY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COGNITIVE DEFECT; CONCEPT FORMATION; CONSENSUS DEVELOPMENT; CONTROLLED STUDY; DEPTH PERCEPTION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; EUROPE; HUMAN; MAJOR CLINICAL STUDY; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; OCCUPATIONAL EXPOSURE; PATIENT COUNSELING; PREDICTION; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; VERBAL MEMORY; VISUAL MEMORY;

AIR POLLUTANTS, OCCUPATIONAL; ATTENTION; BRAIN; CHRONIC DISEASE; COGNITION; CONSENSUS; HUMANS; MENTAL RECALL; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; NEUROTOXICITY SYNDROMES; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SOLVENTS; TIME FACTORS; VISUAL PERCEPTION;

EID: 84864510169     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2012.03.010     Document Type: Article

References (102)

1. åbjörnsson G., Palsson B., Bergendorf U., Karlson B., österberg K., Seger L., et al. Long-term follow-up of psychological distress, social functioning, and coping style in treated and untreated patients with solvent-induced chronic toxic encephalopathy. J Occup Environ Med 1998, 40:801-807.
2. Akila R., Muller K., Kaukiainen A., Sainio M. Memory performance profile in occupational chronic solvent encephalopathy suggests working memory dysfunction. J Clin Exp Neuropsychol 2006, 28:1307-1326.
3. American Psychiatric Association DSM-IV-TR. Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington, DC, USA. 4th ed. text revision.
4. Anger W.K., Liang Y.X., Nell V., Kang S.K., Cole D., Bazylewicz-Walczak B., et al. Lessons learned - 15 years of the WHO-NCTB: a review. Neurotoxicology 2000, 21:837-846.
5. Anger W.K. Neurobehavioural tests and systems to assess neurotoxic exposures in the workplace and community. Occup Environ Med 2003, 60:531-538. 474.
6. Anger W.K., Letz R., Chrislip D.W., Frumkin H., Hudnell K., Russo J.M., et al. Neurobehavioral test methods for environmental health studies of adults. Neurotoxicol Teratol 1994, 16:489-497.
7. Antti-Poika M. Overall prognosis of patients with diagnosed chronic organic solvent intoxication. Int Arch Occup Environ Health 1982, 51:127-138.
8. Arlien-Søborg P., Bruhn P., Gyldensted C., Melgaard B. Chronic painters' syndrome. Chronic toxic encephalopathy in house painters. Acta Neurol Scand 1979, 60:149-156.
9. Baker E.L. A review of recent research on health effects of human occupational exposure to organic solvents. A critical review. J Occup Med 1994, 36:1079-1092.
10. Baker E.L., Seppäläinen A.M. Human aspects of neurobehavioral effects. Report of the workshop session on clinical and epidemiological topics. Neurotoxicology 1986, 7:45-56.
11. Bast-Pettersen R. Self-reported conceptions of memory and concentration in comparison with the neuropsychological test performance of manual workers. Scand J Work Environ Health 2006, 2(Suppl.):41-46.
12. Bast-Pettersen R. The neuropsychological diagnosis of chronic solvent induced encephalopathy (CSE) - a reanalysis of neuropsychological test results in a group of CSE patients diagnosed 20 years ago, based on comparisons with matched controls. Neurotoxicology 2009, 30:1195-1201.
13. Bendiksen M.S., Bendiksen I. A multi-dimensional intervention for a toxic solvent injured population. J Cogn Rehab 1992, 10:20-26.
14. Bertstad J., Flekkøy K., Pedersen O.N. Encephalopathy and polyneuropathy induced by organic solvents. J Oslo City Hosp 1989, 39:81-86.
15. Binder L.M., Iverson G.L., Brooks B.L. To err is human: " abnormal" neuropsychological scores and variability are common in healthy adults. Arch Clin Neuropsychol 2009, 24:31-46.
16. Bruhn P., Arlien-Soborg P., Gyldensted C., Christensen E.L. Prognosis in chronic toxic encephalopathy. A two-year follow-up study in 26 house painters with occupational encephalopathy. Acta Neurol Scand 1981, 64:259-272.
17. Burstyn I., Kromhout H. Trends in inhalation exposure to hydrocarbons among commercial painters in The Netherlands. Scand J Work Environ Health 2002, 28:429-438.
18. Caldwell D.J., Armstrong T.W., Barone N.J., Suder J.A., Evans M.J. Hydrocarbon solvent exposure data: compilation and analysis of the literature. Aihaj 2000, 61:881-894.
19. Campo P., Maguin K. Solvent-induced hearing loss: mechanisms and prevention strategy. Int J Occup Med Environ Health 2007, 20:265-270.
20. Carter N., Iregren A., Soderman E., Olson B.A., Karlson B., Lindelof B., et al. EUROQUEST - a questionnaire for solvent related symptoms: factor structure, item analysis and predictive validity. Neurotoxicology 2002, 23:711-717.
21. Castillo L., Baldwin M., Sassine M.P., Mergler D. Cumulative exposure to styrene and visual functions. Am J Ind Med 2001, 39:351-360.
22. Chen R., Dick F., Semple S., Seaton A., Walker L.G. Exposure to organic solvents and personality. Occup Environ Med 2001, 58:14-18.
23. Condray R., Morrow L.A., Steinhauer S.R., Hodgson M., Kelley M. Mood and behavioral symptoms in individuals with chronic solvent exposure. Psychiatry Res 2000, 97:191-206.
24. DGUV, Occupational Disease Report 2/2007e. Occupational disease no. 1317 - polyneuropsthy or encephalopathy caused by organic solvents, in isolation or in mixtures. Eds: DGUV Deutsche Gesetzliche Unfallversicherung, Belin; July 2010.
25. Dryson E.W., Ogden J.A. Organic solvent induced chronic toxic encephalopathy: extent of recovery, and associated factors, following cessation of exposure. Neurotoxicology 2000, 21:659-665.
26. Edling C., Ekberg K., Ahlborg G., Alexandersson R., Barregard L., Ekenvall L., et al. Long-term follow up of workers exposed to solvents. Br J Ind Med 1990, 47:75-82.
27. Egeland J., Langfjaeran T. Differentiating malingering from genuine cognitive dysfunction using the trail making test-ratio and stroop interference scores. Appl Neuropsychol 2007, 14:113-119.
28. Ellingsen D.G., Lorentzen P., Langård S. A neuropsychological study of patients exposed to organic solvents. Int J Occup Environ Health 1997, 3:177-183.
29. Eskelinen L., Luisto M., Tenkanen L., Mattei O. Neuropsychological methods in the differentiation of organic solvent intoxication from certain neurological conditions. J Clin Exp Neuropsychol 1986, 3:239-256.
30. European Commission, Directorate-General for Employment, Social Affairs and Equal Opportunities, F4 Unit. Information notices on occupational diseases: a guide to diagnosis, January 2009.
31. Fidler A.T., Baker E.L., Letz R.E. Neurobehavioural effects of occupational exposure to organic solvents among construction painters. Br J Ind Med 1987, 44:292-308.
32. Gade A., Mortensen E.L., Bruhn P. Chronic painter's syndrome". A reanalysis of psychological test data in a group of diagnosed cases, based on comparisons with matched controls. Acta Neurol Scand 1988, 77:293-306.
33. Ganzevles P.G.J., de Geus B.W.J. Clinical neuropsychological assessment of patients chronically exposed to organic solvents. Arch Toxicol 1992, (Suppl. 15):54-57.
34. Gazzaniga M.S., Ivry R.B., Mangun G.R. Cognitive neuroscience: the biology of the mind 2002, W.W. Norton & Company Inc., New York. 2nd ed.
35. Gobba F. Olfactory toxicity: long-term effects of occupational exposures. Int Arch Occup Environ Health 2006, 79:322-331.
36. Godderis L., Dours G., Laire G., Viaene M.K. Sleep apnoeas and neurobehavioral effects in solvent exposed workers. Int J Hyg Environ Health 2011, 214:66-70.
37. Godderis L., Maertens N., de Gelder V., De Lamper A., De Ruyck K., Vernimmen M., et al. Genetic susceptibility in solvent induced neurobehavioral effects. Neurotox Res 2010, 17:268-278.
38. Green P., Iverson G.L., Allen L. Detecting malingering in head injury litigation with the Word Memory Test. Brain Inj 1999, 13:813-819.
39. Gregersen P., Klausen H., Elsnab C.U. Chronic toxic encephalopathy in solvent-exposed painters in Denmark 1976-1980: clinical cases and social consequences after a 5 year follow-up. Am J Ind Med 1987, 11:399-417.
40. Greve K.W., Bianchini K.J., Black F.W., Heinly M.T., Love J.M., Swift D.A., et al. The prevalence of cognitive malingering in persons reporting exposure to occupational and environmental substances. Neurotoxicology 2006, 27(6):940-950.
41. Hänninen H. The psychological performance profile in occupational intoxications. Neurotoxicol Teratol 1988, 10:485-488.
42. Haut M.W., Kuwabara H., Ducatman A.M., Hatfield G., Parsons M.W., Scott A., et al. Corpus callosum volume in railroad workers with chronic exposure to solvents. J Occup Environ Med 2006, 48:615-624. [Erratum in: J Occup Environ Med 2008;50:601].
43. Hedden T., Gabrieli J.D. Insights into the ageing mind: a view from cognitive neuroscience. Nat Rev Neurosci 2004, 5:87-96.
44. Heilbronner R.L., Sweet J.J., Morgan J.E., Larrabee G.J., Millis S.R. Conference Participants. American academy of clinical neuropsychology consensus conference statement on the neuropsychological assessment of effort, response bias, and malingering. Clin Neuropsychol 2009, 23:1093-1129.
45. Hooisma J., Emmen H. Onderzoek naar grenswaarden voor de Neurotoxic Symptom Checklist-60 (NSC-60). TNO Rijswijk 1992.
46. Prevention of neurotoxic illness in working populations 1987, John Wiley and Sons, New York. B.L. Johnson, E.L. Baker, M. El Batawi, R. Gilioli, H. Hanninen, A.M. Seppalainen, C. Xintaras (Eds.).
47. Juntunen J., Antti-Poika M., Tola S., Partanen T. Clinical prognosis of patients with diagnosed chronic solvent intoxication. Acta Neurol Scand 1982, 65:488-493.
48. Karlson B., österberg K., Ørbæk P. Euroquest: the validity of a new symptom questionnaire. Neurotoxicology 2000, 21:783-789.
49. Kaukiainen A., Akila R., Martikainen R., Sainio M. Symptom screening in detection of occupational solvent-related encephalopathy. Int Arch Occup Environ Health 2009, 82:343-355.
50. Kaukiainen A., Hyvärinen H.K., Akila R., Sainio M. Symptoms of chronic solvent encephalopathy: euroquest questionnaire study. Neurotoxicology 2009, 30:1187-1194.
51. Keski-Säntti P., Holm A., Akila R., Tuisku K., Kovala T., Sainio M. P300 of auditory event related potentials in occupational chronic solvent encephalopathy. Neurotoxicology 2007, 28:1230-1236.
52. Keski-Säntti P., Kaukiainen A., Hyvärinen H.K., Sainio M. Occupational chronic solvent encephalopathy in Finland 1995-2007: incidence and exposure. Int Arch Occup Environ Health 2010, 83:703-712.
53. Keski-Säntti P., Mäntylä R., Lamminen A., Hyvärinen H.K., Sainio M. Magnetic resonance imaging in occupational chronic solvent encephalopathy. Int Arch Occup Environ Health 2009, 82:595-602.
54. Kolb B., Whishaw I.Q. An introduction to brain and behavior 2006, Worth Publishers, New York. 2nd ed.
55. Korbo L., Ladefoged O., Lam H.R., Ostergaard G., West M.J., Arlien-Søborg P. Neuronal loss in hippocampus in rats exposed to toluene. Neurotoxicology 1996, 17:359-366.
56. Lezak M.D., Howieson D.B., Loring D.W. Neuropsychological assessment 2004, Oxford University Press. 4th ed.
57. Lindgren M., österberg K., Ørbæk P., Rosén I. Solvent-induced toxic encephalopathy: electrophysiological data in relation to neuropsychological findings. J Clin Exp Neuropsychol 1997, 5:772-783.
58. Linz D.H., de Garmo P.L., Morton W.E., Wiens A.N., Coull B.M., Maricle R.A. Organic solvent-induced encephalopathy in industrial painters. J Occup Med 1986, 28:119-125.
59. Lomax R.B., Ridgway P., Meldrum M. Does occupational exposure to organic solvents affect colour discrimination?. Toxicol Rev 2004, 23:91-121.
60. Lundberg I., Högberg M., Michélsen H., Nise G., Hogstedt C. Evaluation of the Q16 questionnaire on neurotoxic symptoms and a review of its use. Occup Environ Med 1997, 54:343-350.
61. Lundberg I., Michélsen H., Nise G., Hogstedt C., Högberg M., Alferdsson L., et al. Neuropsychiatric function of housepainters with previous long-term heavy exposure to organic solvents. Scand J Work Environ Health 1995, 21(Suppl. 1):1-44.
62. McDermott C., Allshire A., van Pelt F.N., Heffron J.J. Validation of a method for acute and subchronic exposure of cells in vitro to volatile organic solvents. Toxicol In Vitro 2007, 21:116-124.
63. Mergler D., Blain L. Assessing color vision loss among solvent-exposed workers. Am J Ind Med 1987, 12:195-203.
64. Meyer-Baron M., Blaszkewicz M., Henke H., Knapp G., Muttray A., Schaper M., et al. The impact of solvent mixtures on neurobehavioral performance: conclusions from epidemiological data. Neurotoxicology 2008, 29:349-360.
65. Mikkelsen S., Jørgensen M., Browne E., Gyldensted C. Mixed solvent exposure and organic brain damage. A study of painters. Acta Neurol Scand 1988, (Suppl.):1-143.
66. Mikkelsen S. Epidemiological update on solvent neurotoxicity. Environ Res 1997, 73:101-112.
67. Morrow L.A., Gibson C., Bagovich G.R., Stein L., Condray R., Scott A. Increased incidence of anxiety and depressive disorders in persons with organic solvent exposure. Psychosom Med 2000, 62:746-750.
68. Morrow L.A., Ryan C.M., Hodgson M.J., Robin N. Risk factors associated with persistence of neuropsychological deficits in persons with organic solvent exposure. J Nerv Ment Dis 1991, 179:540-545.
69. Ng T.P., Ong S.G., Lam W.K., Jones G.M. Neurobehavioural effects of industrial mixed solvent exposure in Chinese printing and paint workers. Neurotoxicol Teratol 1990, 12:661-664.
70. Nielsen G.D., Lund S.P., Ladefoged O. Neurological effects of white spirit: contribution of animal studies during a 30-year period. Basic Clin Pharmacol Toxicol 2006, 98:115-123.
71. Nilson L., Barregård L., Bäckman L. Neuropsychological deficits in patients diagnosed with chronic toxic encephalopathy: which tests are most discriminative?. Appl Neuropsychol 1996, 3:140-146.
72. Nilson L., Barregård L., Bäckman L. Trail making test in chronic toxic encephalopathy: performance and discriminative potential. Clin Neuropsychol 1999, 13:314-327.
73. Nordling Nilson L.N., Bäckman L., Sällsten G., Hagberg S., Barregård L. Dose-related cognitive deficits among floor layers with previous heavy exposure to solvents. Arch Environ Health 2003, 58:208-217.
74. Nordling Nilson L., Barregård L., Sällsten G., Hagberg S. Self-reported symptoms and their effects on cognitive functioning in workers with past exposure to solvent-based glues: an 18-year follow-up. In Arch Occup Environ Health 2007, 81:69-79.
75. Nordling Nilson L., Karlson B., Nise G., Malmberg B., Ørbæk P. Delayed manifestations of CNS effects in formerly exposed printers - a 20-year follow-up. Neurotoxicol Teratol 2010, 32:620-626.
76. Nordling Nilson L., Sällsten G., Hagberg S., Bäckman L., Barregård L. Influence of solvent exposure and aging on cognitive functioning: an 18 year follow-up of formerly exposed floor layers and their controls. Occup Environ Med 2002, 59:49-57.
77. Ojanpää H., Näsänen R., Päällysaho J., Akila R., Müller K., Kaukiainen A., et al. Visual search and eye movements in patients with chronic solvent-induced toxic encephalopathy. Neurotoxicology 2006, 27:1013-1023.
78. Ørbæk P., Lindgren M., Olivecrona H., Hæger-Aronsen B. Computed tomography and psychometric test performances in patients with solvent induced chronic toxic encephalopathy and healthy controls. Br J Ind Med 1987, 44:175-179.
79. Ørbæk P., Lindgren M. Prospective clinical and psychometric investigation of patients with chronic toxic encephalopathy induced by solvents. Scand J Work Environ Health 1988, 14:37-44.
80. österberg K., Ørbæk P., Karlson B., Bergendorf U., Seger L. A comparison of neuropsychological tests for the assessment of chronic toxic encephalopathy. Am J Ind Med 2000, 38:666-680.
81. Päällysaho J., Näsänen R., Mäntyjärvi M., Kaukiainen A., Sainio M. Colour vision defects in occupational chronic solvent encephalopathy. Hum Exp Toxicol 2007, 26:375-383.
82. Palmer B.W., Boone K.B., Lesser I.M., Wohl M.A. Base rates of " impaired" neuropsychological test performance among healthy older adults. Arch Clin Neuropsychol 1998, 13:503-511.
83. Ridgway P., Nixon T.E., Leach J.P. Occupational exposure to organic solvents and long-term nervous system damage detectable by brain imaging, neurophysiology or histopathology. Food Chem Toxicol 2003, 41:153-187.
84. Royall D.R., Lauterbach E.C., Cummings J.L., Reeve A., Rummans T.A., Kaufer D.I., et al. Executive control function: a review of its promise and challenges for clinical research. J Neuropsychiatry Clin Neurosci 2002, 14:377-405.
85. Seeber A., Schneider H., Zeller H.J. Ein psychologisch-neurologischer Fragebogen (PNF) als Screeningmethode zur Beschwerdeerfassung bei neurotoxisch Exponierten. Probleme und Ergebnisse der Psychologie 1978, 65:23-43.
86. Schmand B., de Sterke S., Lindeboom J. The Amsterdam short-term memory test 1999, Swets and Zeitlinger, Manual. Lisse.
87. Slavin M.J., Brodaty H., Kochan N.A., Crawford J.D., Trollor J.N., Draper B., et al. Prevalence and predictors of " subjective cognitive complaints" in the Sydney memory and ageing study. Am J Geriatr Psychiatry 2010, 18:701-710.
88. Slick D.J., Sherman E.M., Iverson G.L. Diagnostic criteria for malingered neurocognitive dysfunction: proposed standards for clinical practice and research. Clin Neuropsychol 1999, 13(4):545-561.
89. Tielemans E., Heederik D., Burdorf A., Vermeulen R., Veulemans H., Kromhout H., et al. Assessment of occupational exposures in a general population: comparison of different methods. Occup Environ Med 1999, 56:145-151.
90. Tombaugh T.M. TOMM test of memory malingering. Manual 1996, Multi Health Systems, Toronto.
91. van der Hoek J.A.F., Verberk M.M., Hageman G. Criteria for solvent-induced chronic toxic encephalopathy: a systematic review. Int Arch Occup Environ Health 2000, 73:362-368.
92. van der Hoek J.A.F., Verberk M.M., van der Laan G., Hageman G. Routine diagnostic procedures for chronic encephalopathy induced by solvents: survey of experts. Occup Environ Med 2001, 58:382-385.
93. van Hout M.S., Schmand B., Wekking E.M., Deelman B.G. Cognitive functioning in patients with suspected chronic toxic encephalopathy: evidence for neuropsychological disturbances after controlling for insufficient effort. J Neurol Neurosurg Psychiatry 2006, 77:296-303.
94. van Hout M.S., Schmand B., Wekking E.M., Hageman G., Deelman B.G. Suboptimal performance on neuropsychological tests in patients with suspected chronic toxic encephalopathy. Neurotoxicology 2003, 24:547-551.
95. van Valen E., Wekking E., van der Laan G., Sprangers M., van Dijk F. The course of chronic solvent induced encephalopathy: a systematic review. Neurotoxicology 2009, 30:1172-1186.
96. Verberk M.M., van der Hoek J.A.F., van Valen E., Wekking E.M., van Hout M.S., van der Laan G., et al. Decision rules for assessment of chronic solvent encephalopathy; results in 2370 patients. Neurotoxicology 2012, 33(4):742-752.
97. Viaene M.K., Pauwels W., Veulemens H., Roels H.A., Masschelein R. Neurobehavioural changes and persistence of complaints in workers exposed to stryene in a polyester boat building plant: influence of exposure characteristics and microsomal epoxide hydrolase phenotype. Occup Environ Med 2001, 58:103-112.
98. Visser I., Lavini C., Booij J., Reneman L., Majoie C., de Boer A.G., et al. Cerebral impairment in solvent-induced ecephalopathy. Ann Neurol 2008, 63:572-580.
99. Visser I., Wekking E.M., de Boer A.G., de Joode E.A., van Hout M.S., van Dorsselaer S., et al. Prevalence of psychiatric disorders in patients with chronic solvent induced encephalopathy (CSE). Neurotoxicology 2011, May 13 [Epub ahead of print].
100. White R.F., Proctor S.P. Solvents and neurotoxicity. Lancet 1997, 349:1239-1243.
101. World Health Organization (WHO) Environmental Health 5-Chronic effects of organic solvents on the central nervous system and diagnostic criteria 1985, WHO, Copenhagen.
102. Yücel M., Takagi M., Walterfang M., Lubman D.I. Toluene misuse and long-term harms: a systematic review of the neuropsychological and neuroimaging literature. Neurosci Biobehav Rev 2008, 32:910-926.